SPIA
MIRA icon

Steward Partners Investment Advisory’s MIRA Pharmaceuticals MIRA Stock Holding History

Steward Partners Investment Advisory’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14K Hold
2,000
– – ﹤0.01% 4038
2025
Q4 		$3.02K Hold
2,000
– – ﹤0.01% 3847
2025
Q3 		$2.72K Hold
2,000
– – ﹤0.01% 3840
2025
Q2 		$2.42K Buy
2,000
+1,000
+100% +$1.16K ﹤0.01% 3699
2025
Q1 		$980 Sell
1,000
-2,700
-73% -$3.08K ﹤0.01% 3775
2024
Q4 		$4.22K Buy
3,700
+1,700
+85% +$2.22K ﹤0.01% 3418
2024
Q3 		$2.6K Buy
+2,000
New +$3.19K ﹤0.01% 3384

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Steward Partners Investment Advisory's MIRA Position: Q1 2026 in Review

Steward Partners Investment Advisory held its MIRA Pharmaceuticals (MIRA) position steady in Q1 2026 at 2,000 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4038.

Steward Partners Investment Advisory first reported a position in MIRA in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.22K in Q4 2024. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Steward Partners Investment Advisory held 2,000 shares of MIRA Pharmaceuticals worth $2.14K as of Q1 2026.
  • Steward Partners Investment Advisory left its MIRA Pharmaceuticals share count unchanged in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4038 holding.
  • Steward Partners Investment Advisory first reported a position in MIRA Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Steward Partners Investment Advisory's MIRA Pharmaceuticals position peaked at $4.22K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.